Assaf Kacen

1.4k total citations · 1 hit paper
6 papers, 525 citations indexed

About

Assaf Kacen is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Assaf Kacen has authored 6 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Oncology. Recurrent topics in Assaf Kacen's work include Glycosylation and Glycoproteins Research (2 papers), interferon and immune responses (2 papers) and Peptidase Inhibition and Analysis (2 papers). Assaf Kacen is often cited by papers focused on Glycosylation and Glycoproteins Research (2 papers), interferon and immune responses (2 papers) and Peptidase Inhibition and Analysis (2 papers). Assaf Kacen collaborates with scholars based in Israel and United States. Assaf Kacen's co-authors include Gil Amitai, Sarah Melamed, Shany Doron, Rotem Sorek, Adi Millman, Yaara Oppenheimer‐Shaanan, Daniel Cohen, Yifat Merbl, Yishai Levin and Matthias P. Kramer and has published in prestigious journals such as Nature, Cell and Nature Biotechnology.

In The Last Decade

Assaf Kacen

5 papers receiving 523 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cyclic GMP–AMP signalling protects bacteria against viral infection

2019 370 citations Daniel Cohen, Sarah Melamed et al. Nature profile →

Peers

Countries citing papers authored by Assaf Kacen

Since Specialization

Citations

This map shows the geographic impact of Assaf Kacen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Assaf Kacen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Assaf Kacen more than expected).

Fields of papers citing papers by Assaf Kacen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Assaf Kacen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Assaf Kacen. The network helps show where Assaf Kacen may publish in the future.

Co-authorship network of co-authors of Assaf Kacen

This figure shows the co-authorship network connecting the top 25 collaborators of Assaf Kacen. A scholar is included among the top collaborators of Assaf Kacen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Assaf Kacen. Assaf Kacen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Cdc48 plays a crucial role in redox homeostasis through dynamic reshaping of its interactome during early stationary phase 2025 ·Redox Biology ·(unknown), (unknown), Ohad Yogev, (unknown), (unknown), Assaf Kacen, Yifat Merbl, Tommer Ravid, Dana Reichmann	0
2	Cryo-EM structure of the RADAR supramolecular anti-phage defense complex 2023 ·Cell ·B. Lowey, Nitzan Tal, Alex G. Johnson, Shaun Rawson, Megan L. Mayer, Shany Doron, Adi Millman, Sarah Melamed, Taya Fedorenko, Assaf Kacen, Alexander Brandis, Tevie Mehlman, Gil Amitai, Rotem Sorek, Philip J. Kranzusch	50
3	Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors 2022 ·Nature Biotechnology ·Assaf Kacen, Aaron Javitt, Matthias P. Kramer, David Morgenstern, Tomer Tsaban, Merav D. Shmueli, Guo Ci Teo, Felipe da Veiga Leprevost, Eilon Barnea, Fengchao Yu, Arie Admon, Lea Eisenbach, Yardena Samuels, Ora Schueler‐Furman, Yishai Levin, Alexey I. Nesvizhskii, Yifat Merbl	67
4	Altered Protein Abundance and Localization Inferred from Sites of Alternative Modification by Ubiquitin and SUMO 2021 ·Journal of Molecular Biology ·Adi Ulman, (unknown), Bareket Dassa, Aaron Javitt, Assaf Kacen, Merav D. Shmueli, Avital Eisenberg‐Lerner, Daoud Sheban, (unknown), Emmanuel D. Levy, Yifat Merbl	5
5	Cyclic GMP–AMP signalling protects bacteria against viral infection breakdown → 2019 ·Nature ·Daniel Cohen, Sarah Melamed, Adi Millman, (unknown), Yaara Oppenheimer‐Shaanan, Assaf Kacen, Shany Doron, Gil Amitai, Rotem Sorek	370
6	Revealing the cellular degradome by mass spectrometry analysis of proteasome-cleaved peptides 2018 ·Nature Biotechnology ·(unknown), Aaron Javitt, Avital Eisenberg‐Lerner, Assaf Kacen, Adi Ulman, Daoud Sheban, Bareket Dassa, (unknown), Carmelo Carmona‐Rivera, Matthias P. Kramer, (unknown), (unknown), (unknown), Dalia Elinger, Mariana J. Kaplan, David Morgenstern, Yishai Levin, Yifat Merbl	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact